Medpace Holdings Statistics
Total Valuation
MEDP has a market cap or net worth of $12.53 billion. The enterprise value is $12.26 billion.
| Market Cap | 12.53B |
| Enterprise Value | 12.26B |
Important Dates
The next confirmed earnings date is Monday, July 22, 2024, after market close.
| Earnings Date | Jul 22, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MEDP has 30.98 million shares outstanding. The number of shares has decreased by -0.48% in one year.
| Shares Outstanding | 30.98M |
| Shares Change (YoY) | -0.48% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 17.68% |
| Owned by Institutions (%) | 85.33% |
| Float | 25.43M |
Valuation Ratios
The trailing PE ratio is 41.23 and the forward PE ratio is 35.71. MEDP's PEG ratio is 2.68.
| PE Ratio | 41.23 |
| Forward PE | 35.71 |
| PS Ratio | 6.38 |
| Forward PS | 5.43 |
| PB Ratio | 18.66 |
| P/FCF Ratio | 26.47 |
| PEG Ratio | 2.68 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 30.20, with an EV/FCF ratio of 25.90.
| EV / Earnings | 39.23 |
| EV / Sales | 6.25 |
| EV / EBITDA | 30.20 |
| EV / EBIT | 34.25 |
| EV / FCF | 25.90 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.20.
| Current Ratio | 0.78 |
| Quick Ratio | 0.72 |
| Debt / Equity | 0.20 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.29 |
| Interest Coverage | -79.67 |
Financial Efficiency
Return on equity (ROE) is 59.70% and return on invested capital (ROIC) is 37.86%.
| Return on Equity (ROE) | 59.70% |
| Return on Assets (ROA) | 19.70% |
| Return on Capital (ROIC) | 37.86% |
| Revenue Per Employee | $332,680 |
| Profits Per Employee | $52,967 |
| Employee Count | 5,900 |
| Asset Turnover | 1.24 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MEDP has paid $49.93 million in taxes.
| Income Tax | 49.93M |
| Effective Tax Rate | 13.78% |
Stock Price Statistics
The stock price has increased by +69.19% in the last 52 weeks. The beta is 1.39, so MEDP's price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | +69.19% |
| 50-Day Moving Average | 397.49 |
| 200-Day Moving Average | 334.92 |
| Relative Strength Index (RSI) | 51.54 |
| Average Volume (20 Days) | 204,626 |
Short Selling Information
The latest short interest is 854,209, so 2.76% of the outstanding shares have been sold short.
| Short Interest | 854,209 |
| Short Previous Month | 933,815 |
| Short % of Shares Out | 2.76% |
| Short % of Float | 3.36% |
| Short Ratio (days to cover) | 5.24 |
Income Statement
In the last 12 months, MEDP had revenue of $1.96 billion and earned $312.51 million in profits. Earnings per share was $9.81.
| Revenue | 1.96B |
| Gross Profit | 549.46M |
| Operating Income | 354.69M |
| Pretax Income | 362.43M |
| Net Income | 312.51M |
| EBITDA | 405.89M |
| EBIT | 357.94M |
| Earnings Per Share (EPS) | $9.81 |
Balance Sheet
The company has $407.01 million in cash and $136.16 million in debt, giving a net cash position of $270.85 million or $8.74 per share.
| Cash & Cash Equivalents | 407.01M |
| Total Debt | 136.16M |
| Net Cash | 270.85M |
| Net Cash Per Share | $8.74 |
| Equity (Book Value) | 671.54M |
| Book Value Per Share | 21.67 |
| Working Capital | -211.74M |
Cash Flow
In the last 12 months, operating cash flow was $505.98 million and capital expenditures -$32.63 million, giving a free cash flow of $473.34 million.
| Operating Cash Flow | 505.98M |
| Capital Expenditures | -32.63M |
| Free Cash Flow | 473.34M |
| FCF Per Share | $15.35 |
Margins
Gross margin is 27.99%, with operating and profit margins of 18.07% and 15.92%.
| Gross Margin | 27.99% |
| Operating Margin | 18.07% |
| Pretax Margin | 18.47% |
| Profit Margin | 15.92% |
| EBITDA Margin | 20.68% |
| EBIT Margin | 18.24% |
| FCF Margin | 24.12% |
Dividends & Yields
MEDP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.48% |
| Shareholder Yield | 0.48% |
| Earnings Yield | 2.49% |
| FCF Yield | 3.78% |
Analyst Forecast
The average price target for MEDP is $447.14, which is 10.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $447.14 |
| Price Target Difference | 10.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 15.94% |
| EPS Growth Forecast (5Y) | 17.32% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MEDP has an Altman Z-Score of 8.2 and a Piotroski F-Score of 8.
| Altman Z-Score | 8.2 |
| Piotroski F-Score | 8 |